{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:17:33Z","timestamp":1793276253291,"version":"4.5.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The purpose of this study is to develop a genetic test to aid in diagnosing chronic kidney disease (CKD). One challenge in treating CKD is that 80%\u201390% of people with it are undiagnosed and thus do not access healthcare promptly. The problem arises because early-stage CKD has no overt symptoms, and the current policy is to perform diagnostic tests only when accompanied by risk factors such as old age, hypertension, and diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study describes the development of the RICK (RIsk for Chronic Kidney disease) algorithm that employs a polygenic risk score for CKD plus clinical risk factors to identify people at risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In data from the United Kingdom biobank, those in the top decile of RICK have a ten-fold increased risk of CKD, and approximately 49% of all those with CKD are included in this decile. Furthermore, targeted creatinine testing for those in the highest RICK decile would potentially increase the number of individuals diagnosed with CKD by 7.4%. However, the RICK algorithm adds little value for detecting CKD defined by elevated uACR (albuminuria).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Using RICK to selectively test those in the general population with highest risk may help in the early identification of CKD and facilitate early access to renal healthcare. The effectiveness and cost-effectiveness of such testing require further study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2026.1799312","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:10:31Z","timestamp":1783548631000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A genetic and clinical risk factor algorithm to aid in identifying new cases of chronic kidney disease from the general population"],"prefix":"10.3389","volume":"17","author":[{"given":"Graham","family":"Rodwell","sequence":"first","affiliation":[{"name":"Division of Nephrology, Palo Alto Medical Foundation","place":["Palo Alto, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P. A.","family":"Ioannidis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford Prevention Research Center","place":["Stanford, CA, United States"]},{"name":"Department of Biomedical Data Science, Stanford University School of Medicine","place":["Stanford, CA, United States"]},{"name":"Department of Statistics, Stanford University School of Humanities and Sciences","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart K.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Developmental Biology, Stanford University Medical Center","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000484327","article-title":"Heritability of end-stage renal disease: a Swedish adoption study","volume":"138","author":"Akrawi","year":"2018","journal-title":"Nephron."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.kint.2023.03.017","article-title":"Association of polygenic scores with chronic kidney disease phenotypes in a longitudinal study of older adults","volume":"103","author":"Bakshi","year":"2023","journal-title":"Kidney Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14210","article-title":"Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis","volume":"14","author":"Black","year":"2010","journal-title":"Health Technol. Assess."},{"key":"B4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"Gigascience"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1681\/ASN.2021020167","article-title":"Effects of dapagliflozin in stage 4 chronic kidney disease","volume":"32","author":"Chertow","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.kint.2018.10.031","article-title":"Monogenic causes of chronic kidney disease in adults","volume":"95","author":"Connaughton","year":"2019","journal-title":"Kidney Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1681\/ASN.0000000000000249","article-title":"The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease","volume":"34","author":"Dahl","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.amepre.2017.02.015","article-title":"State-level awareness of chronic kidney disease in the U.S","volume":"53","author":"Dharmarajan","year":"2017","journal-title":"Am. J. Prev. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrneph.2016.163","article-title":"The global burden of chronic kidney disease: estimates, variability and pitfalls","volume":"13","author":"Glassock","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1534\/g3.111.001198","article-title":"Genotype imputation with thousands of genomes","volume":"1","author":"Howie","year":"2011","journal-title":"G3"},{"key":"B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","article-title":"Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data","volume":"135","author":"Jafar","year":"2001","journal-title":"Ann. Intern Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.2215\/CJN.05300515","article-title":"Health education and general practitioner training in hypertension management: long-term effects on kidney function","volume":"11","author":"Jafar","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41591-022-01869-1","article-title":"Genome-wide polygenic score to predict chronic kidney disease across ancestries","volume":"28","author":"Khan","year":"2022","journal-title":"Nat. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/ckj\/sfac240","article-title":"Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999-2018 national health and nutrition examination survey","volume":"16","author":"Kovesdy","year":"2023","journal-title":"Clin. Kidney J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","article-title":"The polygenic score catalog as an open database for reproducibility and systematic evaluation","volume":"53","author":"Lambert","year":"2021","journal-title":"Nat. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ekir.2019.12.003","article-title":"Preventing CKD in developed countries","volume":"5","author":"Luyckx","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/ndt\/gfq792","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials","volume":"26","author":"Maione","year":"2011","journal-title":"Nephrol. Dial. Transpl."},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.kisu.2017.07.004","article-title":"Genetic and environmental risk factors for chronic kidney disease","volume":"7","author":"Obrador","year":"2011","journal-title":"Kidney Int. Suppl."},{"key":"B24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrneph.2011.189","article-title":"Genome-wide association studies of chronic kidney disease: what have we learned?","volume":"8","author":"O\u2019Seaghdha","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.mcna.2004.11.011","article-title":"The familial clustering of renal disease and related phenotypes","volume":"89","author":"Satko","year":"2005","journal-title":"Med. Clin. North Am."},{"key":"B26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2215\/CJN.0000000000000564","article-title":"Utility of genetic testing in adults with chronic kidney disease: a systematic review and meta-analysis: a systematic review and meta-analysis","volume":"20","author":"Schott","year":"2024","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41746-021-00428-1","article-title":"Medical records-based chronic kidney disease phenotype for clinical care and \u201cbig data\u201d observational and genetic studies","volume":"4","author":"Shang","year":"2021","journal-title":"NPJ Digit. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41588-020-00757-z","article-title":"Genetics of 35 blood and urine biomarkers in the UK biobank","volume":"53","author":"Sinnott-Armstrong","year":"2021","journal-title":"Nat. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ndt\/gfaa363","article-title":"Genetics-first approach improves diagnostics of ESKD patients <50 years old","volume":"37","author":"Snoek","year":"2022","journal-title":"Nephrol. Dial. Transpl."},{"key":"B30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.kint.2022.11.013","article-title":"A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease","volume":"103","author":"Steinbrenner","year":"2023","journal-title":"Kidney Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1010105","DOI":"10.1371\/journal.pgen.1010105","article-title":"Significant sparse polygenic risk scores across 813 traits in UK biobank","volume":"18","author":"Tanigawa","year":"2022","journal-title":"PLoS Genet."},{"key":"B33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"SGLT2 inhibitor meta-analysis cardio-renal trialists\u2019 consortium. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"sfad272","DOI":"10.1093\/ckj\/sfad272","article-title":"SGLT2 inhibitors and finerenone in non-diabetic CKD: a step into the (near) future?","volume":"17","author":"Theodorakopoulou","year":"2024","journal-title":"Clin. Kidney J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e3013","DOI":"10.1097\/MD.0000000000003013","article-title":"Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis: a systematic review and exploratory meta-analysis","volume":"95","author":"Tsai","year":"2016","journal-title":"Med. Baltim."},{"key":"B36","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2215\/CJN.06550613","article-title":"Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care","volume":"9","author":"Verhave","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1053\/j.ajkd.2017.05.007","article-title":"Family aggregation and heritability of ESRD in Taiwan: a population-based study","volume":"70","author":"Wu","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1681\/ASN.2020111599","article-title":"Polygenic risk scores for kidney function and their associations with circulating proteome, and incident kidney diseases","volume":"32","author":"Yu","year":"2021","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1799312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:10:33Z","timestamp":1783548633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1799312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":38,"alternative-id":["10.3389\/fgene.2026.1799312"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1799312","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1799312"}}